Cargando…
Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
AIMS/INTRODUCTION: Asprosin is a novel secreted adipokine that is induced by fasting and promotes hepatic glucose release. In healthy humans, circulating asprosin shows circadian oscillation with an acute drop coinciding with the onset of eating. The present study investigated whether this circadian...
Autores principales: | Zhang, Xinyue, Jiang, Hui, Ma, Xiaojing, Wu, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078095/ https://www.ncbi.nlm.nih.gov/pubmed/31529619 http://dx.doi.org/10.1111/jdi.13148 |
Ejemplares similares
-
Increased serum asprosin is correlated with diabetic nephropathy
por: Wang, Rui, et al.
Publicado: (2021) -
Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
por: Jiang, Aijun, et al.
Publicado: (2021) -
Association Between Plasma Asprosin Levels and Gestational Diabetes Mellitus
por: Boz, İbrahim Bekir, et al.
Publicado: (2023) -
Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity
por: Corica, Domenico, et al.
Publicado: (2022) -
Serum concentration of asprosin in new-onset type 2 diabetes
por: Naiemian, Shakiba, et al.
Publicado: (2020)